Researchers are inching closer to understanding how common blood pressure medications might help prevent the growth and spread of pancreatic cancer. They have found in the laboratory that one type of pressure-lowering drug called an angiotensin receptor blocker inhibits pancreatic cancer cell growth and causes cell death. In previous work, they showed that such drugs helped reduce the development of tumor-feeding blood vessels, or angiogenesis.